William T. Bradner
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Oncology top 5%
- Pharmacology top 2%
- Toxicology top 0.5%
- Co-authors
- Stanley T. CrookeJohn E. SchurigJames BushWilliam A. RemersB H LongJ. J. CatinoWilliam C. RoseTerrence W. Doyle
- Topics
- Bioactive Compounds and Antitumor Agents (22 papers)Cancer therapeutics and mechanisms (19 papers)Microbial Natural Products and Biosynthesis (15 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
William T. Bradner
71 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 119
- Molecular Biology 963
- Organic Chemistry 721
- Oncology 510
- Pharmacology 370
- Toxicology 355
Countries citing papers authored by William T. Bradner
This map shows the geographic impact of William T. Bradner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Bradner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Bradner more than expected).
Fields of papers citing papers by William T. Bradner
This network shows the impact of papers produced by William T. Bradner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Bradner. The network helps show where William T. Bradner may publish in the future.
Co-authorship network of co-authors of William T. Bradner
This figure shows the co-authorship network connecting the top 25 collaborators of William T. Bradner. A scholar is included among the top collaborators of William T. Bradner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Bradner. William T. Bradner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 267 | |
| 2 | 8 | |
| 3 | 14 | |
| 4 | 10 | |
| 5 | 18 | |
| 6 | 13 | |
| 7 | 3 | |
| 8 | Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative. | 14 |
| 9 | Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative. | 7 |
| 10 | Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A. | 24 |
| 11 | 3 | |
| 12 | 20 | |
| 13 | 66 | |
| 14 | 1 | |
| 15 | The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin. | 16 |
| 16 | Bleomycin, a review. | 181 |
| 17 | 4 | |
| 18 | Strain specificity of stimulated regression of sarcoma 180. | 6 |
| 19 | Actinogan: a new antitumor agent obtained from Streptomyces. I. Chemical and biological properties. | 7 |
| 20 | 3 |
About William T. Bradner
William T. Bradner is a scholar working on Toxicology, Microbiology and Biotechnology, having authored 71 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (22 papers), Cancer therapeutics and mechanisms (19 papers) and Microbial Natural Products and Biosynthesis (15 papers). The work is most often cited by research in Toxicology (355 citations), Organic Chemistry (721 citations) and Pharmacology (370 citations). William T. Bradner has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Stanley T. Crooke, John E. Schurig, James Bush, William A. Remers, B H Long, J. J. Catino, William C. Rose, Terrence W. Doyle, Donald A. Clarke and Bhashyam S. Iyengar. Their work appears in journals such as Nature, Science and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.